Surgical Therapy for Stage I Lung Cancer—Lobar versus Sublobar Resection
Seminars in Respiratory and Critical Care Medicine · 01.10.2025 · 46 (05) · 428-435
DOI: 10.1055/a-2649-9277 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Respiratory and Critical Care Medicine, erschienen am 01.10.2025. Verfasst von Sarah Rudasill und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Washington, Seattle, Washington. Hauptthemen laut MEDLINE: Lung Neoplasms, Pneumonectomy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: NCI NIH HHS, U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute.
Abstract (Originalsprache)
Lung cancer is a leading cause of cancer-related mortality, but advances in screening and early detection have improved opportunities for curative treatment. Therapeutic intent surgical resection remains a cornerstone for managing clinical stage IA disease. However, the optimal extent of surgical resection in this population has been a subject of ongoing debate. This review, guided by an introductory case-based vignette, provides a primer on the technical aspects of resection, pretreatment patient-level factors underlying decision-making, and other determinants of outcomes that may influence decisions to pursue lobar versus sublobar resection. We then offer a critique of the evidence base, focusing on the results of four randomized controlled trials: the Lung Cancer Study Group, DRKS00004897, JCOG0802/WJOG4607L, and CALGB140503. Following an interpretation of the available evidence, the review highlights contemporary practice patterns and the challenges of preference-based decisions. Finally, evidence gaps are highlighted as opportunities for future study to improve patient outcomes and experiences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, University of Washington, Seattle, Washington.
Förderung
- NCI NIH HHS
- U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute
Zitieren
APA
Rudasill, S., & Farjah, F. (2025). Surgical Therapy for Stage I Lung Cancer—Lobar versus Sublobar Resection. Seminars in Respiratory and Critical Care Medicine, 46(05), 428-435. https://doi.org/10.1055/a-2649-9277
Vancouver
Rudasill S, Farjah F. Surgical Therapy for Stage I Lung Cancer—Lobar versus Sublobar Resection. Seminars in Respiratory and Critical Care Medicine. 2025;46(05):428-435. doi:10.1055/a-2649-9277
BibTeX
@article{Rudasill2025,
author = {Rudasill, Sarah and Farjah, Farhood},
title = {Surgical Therapy for Stage I Lung Cancer—Lobar versus Sublobar Resection},
journal = {Seminars in Respiratory and Critical Care Medicine},
year = {2025},
volume = {46},
number = {05},
pages = {428--435},
doi = {10.1055/a-2649-9277}
}
EUVIMED